Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

3948results about How to "Reduce the overall diameter" patented technology

Multi-filar coil medical stent

Multi-filar, open and closed coil, tubular medical stents that are introduced to a site in a body lumen and released to expand at the site to provide a passageway through the stent lumen are disclosed. Each stent filar is a coil wound in substantially the same pitch through the majority of its length between the ends thereof. The coils are attached together at least at one coil end to form an end of the stent and wound in an interleaved manner such that the adjacent coils are substantially evenly spaced apart or in close contact in the released state and do not cross over one another. In one open coil stent embodiment, both ends of each coil are attached in respective first and second common attachment junctions, and the resulting coils have relatively even predetermined spacing between adjacent coil turns through the majority of the length of the stent between the first and last coil turns when the stent is released. Preferably, the first and second stent ends are formed by attaching the coil ends in common, and the stent ends are squared by decreasing the pitch of the first coil turn extending from the stent end such that the spacing of the stent end from the adjacent coil is reduced from the predetermined spacing. Additionally, multi-filar closed coil stent embodiments are disclosed having only one end of each coil attached in common and adjacent coil turns in substantial mutual and overlying contact in the restrained state during implantation and non-overlying contact in the released state. Preferably each common attachment junction of attached coil ends and each free coil end is formed into an enlarged stent end in at least one dimension for ease of attachment to and release from a stent delivery catheter. The common attachment junction can be snared or grasped by a stent retrieval system and retracted from the body lumen.
Owner:MEDTRONIC INSTENT

Annuloplasty rings for repair of abnormal mitral valves

A remodeling mitral annuloplasty ring with a reduced anterior-to-posterior dimension to restore coaptation between the mitral leaflets in mitral valve insufficiency (IMVI). The ring has a generally oval shaped body with a major axis perpendicular to a minor axis, both perpendicular to a blood flow axis. An anterior section lies between anteriolateral and posteriomedial trigones, while a posterior section defines the remaining ring body and is divided into P1, P2, and P3 segments corresponding to the three scallops of the same nomenclature in the posterior leaflet of the mitral valve. The anterior-to-posterior dimension of the ring body is reduced from conventional rings; such as by providing, in atrial plan view, a pulled-in P3 segment. Viewed another way, the convexity of the P3 segment is less pronounced than the convexity of the P1 segment. In addition, the ring body may have a downwardly deflected portion in the posterior section, preferably within the P2 and P3 segments. The downwardly deflected portion may have an apex which is the lowest elevation of the ring body and may be offset with respect to the center of the downwardly deflected portion toward the P1 segment. A sewing cuff may have an enlarged radial dimension of between 5-10 cm, or only a portion of the sewing cuff may be enlarged.
Owner:EDWARDS LIFESCIENCES CORP

Shrinkage of dilatations in the body

A method and system for shrinking dilatations of a body, removing excess, weak or diseased tissue, and strengthening remaining tissues of the lumen walls. A catheter is disposed near the dilatation and fixed in position by inflatable occlusion balloons. Body fluids present in the occluded dilatation are evacuated and treatment fluid is exuded under pressure into the dilatation. Pressure is maintained by the treatment fluid while energy is applied by the catheter to heat the treatment fluid, causing the lumen walls to absorb the treatment fluid. Additional energy is then applied so as to preferentially heat the lumen wall tissues which have absorbed the treatment fluid, while at the same time treatment fluid is circulated to cool the inner surface of the lumen walls. The dilatation is occluded, a saline solution is introduced and absorbed into the lumen-wall tissue in the occluded region of the dilatation and then heated by application of radio frequency (“RF”) or other energy in order to soften only the lumen-wall tissue of the dilatation, the dilatation is shrunk by application of a chilled saline solution and a vacuum, and additional RF or other energy is emitted to ablate, further shrink, and harden only the lumen-wall tissue of the dilatation, without destroying the inner surface of the lumen or other tissues of the body beyond the lumen walls, thereby promoting growth of epithelial cells.
Owner:EDWARDS STUART D
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products